Clinical trials
Phase 4 Brain Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 7 |
| 2016 | 3 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kaohsiung Medical University Chung-Ho Memorial Hospital | 2 |
| M.D. Anderson Cancer Center | 2 |
| AdventHealth | 1 |
| Aga Khan University | 1 |
| Baskent University | 1 |
| Bracco Diagnostics, Inc | 1 |
| Chiang Mai University | 1 |
| City of Hope Medical Center | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 34 |
| Breast Neoplasms | 3 |
| Epilepsy | 3 |
| Neoplasm Metastasis | 3 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
| Ovarian Neoplasms | 2 |
| Seizures | 2 |
| Acromegaly | 1 |
| Brain Concussion | 1 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.